Acquired Von Willebrand Syndrome (AVWS) in cardiovascular disease: a state of the art review for clinicians.

Von Willebrand Factor (vWF) is a large glycoprotein with a broad range of physiological and pathological functions in health and disease. While vWF is critical for normal hemostasis, vascular integrity and repair, quantitative and qualitative abnormalities in the molecule can predispose to serious bleeding and thrombosis. The heritable form of von Willebrand Disease was first described nearly a century ago, but more recently, recognition of an acquired condition known as acquired von Willebrand Syndrome (AVWF) has emerged in persons with hematological, endocrine and cardiovascular diseases, disorders and conditions. An in-depth understanding of the causes, diagnostic approach and management of AVWS is important for practicing clinicians.

Anterior-Segment Optical Coherence Tomography-Based Evaluation of the Journey of a Bleb in the Early Postoperative Period.

Introduction In the early postoperative period following trabeculectomy, monitoring the journey of bleb formation is crucial for assessing surgical success. Anterior-segment optical coherence tomography (AS-OCT) emerges as a powerful tool in this pursuit, offering high-resolution imaging of bleb morphology and dynamics. This study aims to evaluate the internal structure of blebs through their maturation phases using AS-OCT. Methods Fifty-five eyes undergoing trabeculectomy were enrolled in a prospective observational study. Serial AS-OCT examinations were done on day 1, week 1, week 3, and week 6 postoperatively; bleb parameters were calculated and correlated with intraocular pressure (IOP). Results IOP control was seen in 45 eyes six months of post-trabeculectomy. Multiform bleb wall reflectivity (BWR) statistically correlates with the success of trabeculectomy. Blebs were successful if BWR showed no change from day 1 to week 6. BWR remained the same on all follow-ups if week 1 bleb wall thickness (BWT) was less than 129.5 microns with 82.6% sensitivity and 83.3% specificity. The cumulative hazard of change in BWR is estimated to be approximately 5.6%, 15.7%, and 17.9% at week 1, week 3, and week 6 follow-ups, respectively. Conclusions Successful blebs showed consistent BWR from day 1 to week 6 of follow-up. Serial AS-OCT examination for changes in BWR in early stages can be done to predict the fate of bleb. The maximum change in BWR occurs between the week 1 and week 3 follow-up periods requiring close follow-up.

Does smoking affect the outcomes of lumbar decompression surgery?

INTRODUCTION: Lumbar decompressions and micro-discectomies are commonly performed non-complex spinal surgeries that do not involve the insertion of metalwork into the spine and are done for symptomatic disc prolapse and lumbar spinal stenosis, whereas complex-spinal surgery does require metalwork [1]. Studies of complex-spinal surgeries show that smoking has a significant negative impact on the outcome of the surgery [2] therefore, the cessation of smoking is advised prior to surgery [3]. There are evidences in the literature supportive as well as opposing this statement about continued smoking and poor outcome of decompressive spinal surgeries. METHODS: We retrospectively reviewed 143 consecutive patients who have had either a micro-discectomy or a micro-decompression. RESULTS: We found no statistical difference between smokers and non-smokers in the outcomes of lumbar decompression surgery. Both groups improved equally and significantly in terms of back pain, leg pain and functions. Out of 143 patients, only 2% more non-smokers had improved leg pain compared to smokers, 1% less non-smokers had improved back pain and 2% more non-smokers had an improved Oswestry Disability Index (ODI) score. DISCUSSION: We recommend that it is important to surgically treat both smokers and non-smokers in need of a lumbar spinal decompression.